-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Palvella Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2020 to Q3 2025.
- Palvella Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2025 was 11.1M shares, a 525% increase year-over-year.
- Palvella Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 2.23M shares, a 24.1% increase from 2023.
- Palvella Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 1.79M shares.
- Palvella Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 64.5M shares, a 18.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)